12/22
11:03 am
ilmn
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
12/22
08:02 am
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $112.00 to $130.00. They now have a "hold" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $112.00 to $130.00. They now have a "hold" rating on the stock.
12/17
04:35 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/16
04:05 pm
ilmn
Illumina To Webcast Upcoming Investor Conference
Low
Report
Illumina To Webcast Upcoming Investor Conference
12/15
02:24 pm
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.
12/15
06:04 am
ilmn
Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
12/11
04:19 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
09:39 am
ilmn
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance]
Low
Report
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance]
12/11
09:15 am
ilmn
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Low
Report
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
12/5
04:22 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
12/4
07:18 am
ilmn
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/29
03:36 pm
ilmn
Illumina (NASDAQ:ILMN) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Low
Report
Illumina (NASDAQ:ILMN) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
11/18
08:01 am
ilmn
Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]
Medium
Report
Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]
11/12
12:33 pm
ilmn
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]
Low
Report
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]
11/12
12:00 pm
ilmn
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
Low
Report
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
11/11
04:05 pm
ilmn
Illumina To Webcast Upcoming Investor Conference
Low
Report
Illumina To Webcast Upcoming Investor Conference
11/10
01:02 pm
ilmn
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks [Yahoo! Finance]
Low
Report
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks [Yahoo! Finance]
11/10
12:15 pm
ilmn
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Low
Report
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
11/5
05:16 pm
ilmn
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Medium
Report
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
10/31
02:44 pm
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at TD Cowen from $110.00 to $115.00. They now have a "hold" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at TD Cowen from $110.00 to $115.00. They now have a "hold" rating on the stock.
10/31
02:43 pm
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $105.00. They now have a "neutral" rating on the stock.
Low
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $105.00. They now have a "neutral" rating on the stock.
10/31
11:03 am
ilmn
Illumina (NASDAQ:ILMN) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Medium
Report
Illumina (NASDAQ:ILMN) had its "hold" rating reaffirmed by analysts at Cowen Inc.
10/31
11:01 am
ilmn
Illumina (NASDAQ:ILMN) was given a new $109.00 price target on by analysts at Robert W. Baird.
Medium
Report
Illumina (NASDAQ:ILMN) was given a new $109.00 price target on by analysts at Robert W. Baird.
10/31
09:52 am
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Evercore ISI from $132.00 to $142.00. They now have an "outperform" rating on the stock.
Medium
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at Evercore ISI from $132.00 to $142.00. They now have an "outperform" rating on the stock.
10/31
09:26 am
ilmn
Illumina (NASDAQ:ILMN) had its price target raised by analysts at UBS Group AG from $110.00 to $120.00. They now have a "neutral" rating on the stock.
High
Report
Illumina (NASDAQ:ILMN) had its price target raised by analysts at UBS Group AG from $110.00 to $120.00. They now have a "neutral" rating on the stock.